2016
DOI: 10.18632/oncotarget.12449
|View full text |Cite
|
Sign up to set email alerts
|

Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer

Abstract: Lipopolysaccharide (LPS) exists in the outer membrane of Gram-negative bacteria. Colorectal normal epithelium and colorectal cancer cells in situ are continuously exposed to LPS from intestinal bacteria, while little is known about the influence of LPS on colorectal cancer progression and metastasis. In this study, we investigated the potential role of LPS on colorectal cancer progression and metastasis as well as the underlying mechanisms. We measured higher LPS concentration in colorectal cancer tissues and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
66
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 70 publications
(75 citation statements)
references
References 39 publications
9
66
0
Order By: Relevance
“…Activation of NF‐κB can be directly linked to VEGFC upregulation, because VEGFC upregulation, which is induced by TNFSF15, can be inhibited when treated with either NF‐κB inhibitor PDTC or NF‐κB subunit p65 siRNA in A549 cells. Our finding is consistent with previous studies on ovarian or colon cancer that NF‐κB activation can induce the production of VEGFC …”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Activation of NF‐κB can be directly linked to VEGFC upregulation, because VEGFC upregulation, which is induced by TNFSF15, can be inhibited when treated with either NF‐κB inhibitor PDTC or NF‐κB subunit p65 siRNA in A549 cells. Our finding is consistent with previous studies on ovarian or colon cancer that NF‐κB activation can induce the production of VEGFC …”
Section: Discussionsupporting
confidence: 93%
“…Our finding is consistent with previous studies on ovarian or colon cancer that NF-κB activation can induce the production of VEGFC. 10,12,30 In summary, this study indicates that cytokine TNFSF15 pro- F I G U R E 6 Tumor necrosis factor superfamily 15 (TNFSF15) facilitates vascular endothelial growth factor-C (VEGFC)-stimulated lymphatic endothelial cell (LEC) migration and proliferation. A, Changes in VEGFC protein levels following TNFSF15 treatment in the presence or absence of VEGFC shRNA.…”
Section: Discussionmentioning
confidence: 99%
“…Despite certain unexpected results, our in vivo study has for the first‐time provided the evidence that systemic administration of LPS could activate NF‐κB in PCa cells (Figures A and B) and enhance PCa cells metastasis in a cell line dependent manner (Figure A). We believe that, this effect could be through both direct and indirect methods of LPS‐mediated NF‐κB activation in PCa cells . No metastasis was observed in our DU145 orthotopic tumor model that confirms previously reported less metastatic nature of these cells .…”
Section: Discussionsupporting
confidence: 90%
“…14,19 LPS-mediated local inflammation and/or tissue damage in organs like lung favours metastasis to these sites. 20 Together, LPS could promote cancer cells' metastasis through its direct 18,[21][22][23][24][25][26][27] and/ or indirect effect 14,20,[28][29][30][31][32][33][34] on cancer cells.…”
mentioning
confidence: 99%
“…Although VEGF-C mRNA levels were not increased in the macrophages cultured on NPS substrates, they were increased in pro-inflammatory (m1) media on both substrate types. This finding is consistent with the recently published reports stating that THP-1derived macrophages stimulated by LPSs (common proinflammatory compounds) react by increasing VEGF-C expression (Zhang et al, 2014;Zhu et al, 2016).…”
Section: Scaffold Activates Macrophages To a Pro-angiogenic Potentialsupporting
confidence: 93%